Cargando…
Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine
Bladder cancer (BCa) is a common malignancy worldwide and has a high probability of recurrence after initial diagnosis and treatment. As a result, recurrent surveillance, primarily involving repeated cystoscopies, is a critical component of post diagnosis patient management. Since cystoscopy is inva...
Autores principales: | Wittmann, Bryan M., Stirdivant, Steven M., Mitchell, Matthew W., Wulff, Jacob E., McDunn, Jonathan E., Li, Zhen, Dennis-Barrie, Aphrihl, Neri, Bruce P., Milburn, Michael V., Lotan, Yair, Wolfert, Robert L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277370/ https://www.ncbi.nlm.nih.gov/pubmed/25541698 http://dx.doi.org/10.1371/journal.pone.0115870 |
Ejemplares similares
-
Metabolomics and its Application to the Development of Clinical Laboratory Tests for Prostate Cancer
por: McDunn, Jonathan E., et al.
Publicado: (2015) -
Metabolomics analysis reveals distinct profiles of nonmuscle‐invasive and muscle‐invasive bladder cancer
por: Sahu, Divya, et al.
Publicado: (2017) -
Urine protein biomarkers of bladder cancer arising from 16-plex antibody-based screens
por: Vanarsa, Kamala, et al.
Publicado: (2021) -
Review of the Clinical Approaches to the Use of Urine-based Tumor Markers in Bladder Cancer
por: Clinton, Timothy, et al.
Publicado: (2017) -
Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics
por: Pinto, Joana, et al.
Publicado: (2021)